Max Marchione on Building SuperPower, Compounding Economics, and Clinical Authority | MTS Live

Max Marchione joins MTS to discuss how peptides work as therapeutic modalities, the economic landscape for compounding pharmacies and peptide brands, and the research gaps around safety and efficacy data.--https://x.com/maxmarchione–MTS is a live news and interview show covering technology, business, politics, and culture as it happens.Follow MTS: X | ⁠https://twitter.com/MTSlive⁠YouTube | ⁠https://www.youtube.com/@mtsituation⁠Spotify | ⁠https://open.spotify.com/show/4HUNNmV1pjV7CW6Lphm1rM⁠ Apple | ⁠https://podcasts.apple.com/us/podcast/mts/id1891088763⁠ Substack | ⁠https://mtslive.substack.com/⁠Interested in sponsoring the show? ⁠⁠⁠⁠⁠⁠[email protected]⁠⁠–Brought to you by:Granola - The AI notepad. Try it once and never go back. https://granola.ai/mtsKong - The AI connectivity platform. Connect APIs, LLMs, agents, and systems with serious security and governance. https://konghq.comBlitzy - Autonomous software development for enterprise codebases. Ship 5x faster. https://blitzy.comMerge - OpenAI, Dropbox, and Ramp use Merge to get AI to production faster. https://merge.dev/mtsAdQuick - Make your brand a billboard. Out-of-home advertising as easy to scale as digital. https://adquick.comMacroscope - AI codebase understanding for engineering leaders. https://macroscope.com/mts–Note: This podcast is not investment, legal, or tax advice, and is intended for informational and entertainment purposes only. Hosts and guests may hold positions in the companies and securities discussed; do your own research before acting on anything you hear.--Timestamps:(00:00) Introduction(00:57) What Are Peptides(04:15) Personalized Medicine and Sleep Protocols(09:05) Peptide Stacks and Bioregulators(10:10) Launching SuperPower Peptides(13:04) GLP-1 Microdosing Strategy(17:59) Username Strategy and Community Building(20:40) Clinical Authority and Doctor Education(25:01) Patent Economics and Market Structure(31:06) Manufacturing and Research Gaps--Note: This podcast is not investment, legal, or tax advice, and is intended for informational and entertainment purposes only. Hosts and guests may hold positions in the companies and securities discussed; do your own research before acting on anything you hear